Sarepta Therapeutics Statistics

Total Valuation

LON:0L35 has a market cap or net worth of GBP 8.03 billion. The enterprise value is 8.20 billion.

Market Cap	8.03B
Enterprise Value	8.20B

Important Dates

The next estimated earnings date is Friday, February 28, 2025.

Earnings Date	Feb 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+13.80%
Shares Change (QoQ)	+1.32%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	91.14M

Valuation Ratios

The trailing PE ratio is 88.34.

PE Ratio	88.34
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	9.02
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 52.10, with an EV/FCF ratio of -23.37.

EV / Earnings	90.22
EV / Sales	6.32
EV / EBITDA	52.10
EV / EBIT	127.96
EV / FCF	-23.37

Financial Position

The company has a current ratio of 3.84, with a Debt / Equity ratio of 1.16.

Current Ratio	3.84
Quick Ratio	2.45
Debt / Equity	1.16
Debt / EBITDA	7.11
Debt / FCF	-3.01
Interest Coverage	4.23

Financial Efficiency

Return on equity (ROE) is 12.27% and return on invested capital (ROIC) is 2.11%.

Return on Equity (ROE)	12.27%
Return on Assets (ROA)	1.51%
Return on Invested Capital (ROIC)	2.11%
Return on Capital Employed (ROCE)	2.79%
Revenue Per Employee	931,403
Profits Per Employee	69,185
Employee Count	1,314
Asset Turnover	0.49
Inventory Turnover	2.55

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -21.41% in the last 52 weeks. The beta is 0.75, so LON:0L35's price volatility has been lower than the market average.

Beta (5Y)	0.75
52-Week Price Change	-21.41%
50-Day Moving Average	118.49
200-Day Moving Average	128.05
Relative Strength Index (RSI)	37.60
Average Volume (20 Days)	986

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.88

Income Statement

In the last 12 months, LON:0L35 had revenue of GBP 1.22 billion and earned 90.91 million in profits. Earnings per share was 0.91.

Revenue	1.22B
Gross Profit	454.59M
Operating Income	60.45M
Pretax Income	96.55M
Net Income	90.91M
EBITDA	89.28M
EBIT	60.45M
Earnings Per Share (EPS)	0.91

Full Income Statement

Balance Sheet

The company has 894.12 million in cash and 1.06 billion in debt, giving a net cash position of -161.51 million.

Cash & Cash Equivalents	894.12M
Total Debt	1.06B
Net Cash	-161.51M
Net Cash Per Share	n/a
Equity (Book Value)	911.04M
Book Value Per Share	9.54
Working Capital	1.48B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -262.99 million and capital expenditures -87.97 million, giving a free cash flow of -350.97 million.

Operating Cash Flow	-262.99M
Capital Expenditures	-87.97M
Free Cash Flow	-350.97M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 37.14%, with operating and profit margins of 4.94% and 7.43%.

Gross Margin	37.14%
Operating Margin	4.94%
Pretax Margin	7.89%
Profit Margin	7.43%
EBITDA Margin	7.30%
EBIT Margin	4.94%
FCF Margin	n/a

Dividends & Yields

LON:0L35 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.80%
Shareholder Yield	-13.80%
Earnings Yield	1.13%
FCF Yield	-4.37%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0L35 has an Altman Z-Score of 2.38. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.38
Piotroski F-Score	n/a